Award
National Heart, Lung, and Blood Institute 5R33HL165366-04
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea
Recipient
CINCINNATI CHILDRENS HOSP MED CTR
Award Amount
$4,125,108.00
Ceiling
$4,125,108.00
Awarded
September 06, 2025
Identifier
5R33HL165366-04
A randomized control trial funded by the National Heart Lung and Blood Institute to study oxygen therapy effects on children and adolescents with Down Syndrome and obstructive sleep apnea, with a total funding of approximately $4.1 million for fiscal year 2025.
Description
This project involves a randomized trial to evaluate oxygen therapy in children and adolescents with Down Syndrome and obstructive sleep apnea. The study aims to assess neurocognitive, cardiac, and sleep-related outcomes over a 6-month intervention period.